Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Stallone

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Clinical Kidney Journal|August 15, 2019
To discard or not to discard: transplantation and the art of scoringGiovanni Stallone, Giuseppe Grandaliano
Clinical Kidney Journal|September 29, 2015
Management and prevention of post-transplant malignancies in kidney transplant recipientsGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano
Journal of Nephrology|June 27, 2009
There is a choice for immunosuppressive drug nephrotoxicity: Is it time to change?Giovanni Stallone, Barbara Infante, Loreto Gesualdo
Journal of Nephrology|September 28, 2010
Older donors and older recipients in kidney transplantationGiovanni Stallone, Barbara Infante, Loreto Gesualdo
Journal of Nephrology|July 5, 2012
Acute kidney injury in the elderly populationGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano
Clinical Kidney Journal|December 4, 2023
mRNA as a medicine in nephrology: the future is nowSimona Granata, Giovanni Stallone, Gianluigi Zaza
International Journal of Molecular Sciences|June 9, 2019
mTOR and Aging: An Old Fashioned DressGiovanni Stallone, Barbara Infante, Concetta Prisciandaro, et al.
Transplantation|April 23, 2009
Management of side effects of sirolimus therapyGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano, et al.
Frontiers in Medicine|May 8, 2023
Skin cancer in solid organ transplant recipients: still an open problemSimona Granata, Gianpaolo Tessari, Giovanni Stallone, et al.
Frontiers in Pharmacology|September 9, 2021
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary FibrosisSimona Granata, Pierluigi Carratù, Giovanni Stallone, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Clinical Kidney Journal|August 15, 2019
To discard or not to discard: transplantation and the art of scoringGiovanni Stallone, Giuseppe Grandaliano
Clinical Kidney Journal|September 29, 2015
Management and prevention of post-transplant malignancies in kidney transplant recipientsGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano
Journal of Nephrology|June 27, 2009
There is a choice for immunosuppressive drug nephrotoxicity: Is it time to change?Giovanni Stallone, Barbara Infante, Loreto Gesualdo
Journal of Nephrology|September 28, 2010
Older donors and older recipients in kidney transplantationGiovanni Stallone, Barbara Infante, Loreto Gesualdo
Journal of Nephrology|July 5, 2012
Acute kidney injury in the elderly populationGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano
Clinical Kidney Journal|December 4, 2023
mRNA as a medicine in nephrology: the future is nowSimona Granata, Giovanni Stallone, Gianluigi Zaza
International Journal of Molecular Sciences|June 9, 2019
mTOR and Aging: An Old Fashioned DressGiovanni Stallone, Barbara Infante, Concetta Prisciandaro, et al.
Transplantation|April 23, 2009
Management of side effects of sirolimus therapyGiovanni Stallone, Barbara Infante, Giuseppe Grandaliano, et al.
Frontiers in Medicine|May 8, 2023
Skin cancer in solid organ transplant recipients: still an open problemSimona Granata, Gianpaolo Tessari, Giovanni Stallone, et al.
Frontiers in Pharmacology|September 9, 2021
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary FibrosisSimona Granata, Pierluigi Carratù, Giovanni Stallone, et al.
Pageof 16